what FDA has and hasn't settled
What is the BPC-157 legal status for pharmacies?
BPC-157 has no drug approval. FDA says the review requests were withdrawn, and pharmacies still had no clear answer as of July 2026.
What is the clear FDA answer on BPC-157 today?
FDA still hasn't said that pharmacies may make this peptide. Its 2023 table put BPC-157 in Category 2, the group for ingredients that might carry serious safety risks. A July 23-24, 2026 meeting took advice on whether pharmacies should be allowed to use the ingredient [16]. Three other test compounds, including TB-500, another peptide discussed for tissue repair, were considered too [16].
The meeting offered advice, not a final ruling. FDA hasn't posted the advisers' votes [16]. BPC-157 is still not an FDA-approved drug. FDA listed it in "Category 2" in 2023, but now says the people asking for review withdrew their request [15].
I read those as separate facts. A safety concern warns a pharmacy, a withdrawal ends one request, and a review without a result tells you nothing final about what a pharmacist can do. No public FDA ruling clearly lets a pharmacy make BPC-157 for you. This is general background, not advice about medicine or law.
What changed when the FDA request was withdrawn?
FDA named two lab forms of BPC-157: plain powder and BPC-157 joined to a vinegar-like acid. Both went into Category 2, the safety-concern group, in the September 29, 2023 update [15]. FDA feared that the peptide could stir the immune system, depending on how it entered the body [15]. Unwanted matter and weak checks of the main ingredient worried FDA as well [15].
FDA's page dated April 22, 2026 puts BPC-157 in a table of withdrawn requests [15]. The people or groups seeking review had taken their request back. FDA still hasn't told a compounding pharmacy what to do after that. FDA also hasn't approved BPC-157 as a finished drug, a separate matter [17].
Category 1 is a review group where FDA will often delay action while a pharmacy uses the ingredient, while Category 2 lacks that pause because the possible safety risks are serious [17]. The old BPC-157 listing explains FDA's concern. The withdrawn BPC-157 request gives you no clear way to obtain it.
Did the July 2026 meeting give pharmacies an answer?
No. Outside advisers discussed whether BPC-157 belongs on FDA's list of raw ingredients allowed in a mixed medicine made for one patient [17]. The advisers only give an opinion; FDA decides what to do [17]. The ingredient was on the July 23-24, 2026 meeting plan for that review [16].
The meeting alone didn't allow pharmacy use or change the old Category 2 safety concern [16]. FDA still has to issue its own rule after hearing the advice [17]. FDA staff had already opposed adding BPC-157. The votes and any later ruling still aren't public, so you can't assume the answer.
How do the two kinds of compounding pharmacy differ?
Before anything is made in the U.S., a licensed prescriber must examine the patient, decide whether a specially mixed medicine fits that person's needs, and write the order [18]. A 503A pharmacy holds a state license and fills an order for that one patient. A 503B site registers with FDA, follows tighter factory rules, and may prepare stock in larger lots [18].
A video visit is possible, but the ingredient rules stay the same: you still need actual care from the prescriber plus a lawful prescription before a pharmacy can make anything for you at all [18]. The people or groups who asked FDA to list BPC-157 took back their requests, and the page gives no reason. FDA hasn't told a 503A or 503B pharmacy how to read that change [15][18].
FDA's page dated April 22, 2026 doesn't show BPC-157 in the Category 2 table; the request appears in the withdrawn table. That page still carries FDA's safety worries [15]. This isn't permission to make the ingredient. It only tells you what the agency page showed that day.
What do online products and sports rules add?
BPC-157 isn't an FDA-approved drug for people. Beyond a formal study, a product may have the wrong substance, amount, or level of cleanliness [11]. The small human studies used material checked by researchers. You can't assume that an online product is the same.
Sports rules are a separate issue. The world sports testing body bars athletes from BPC-157 at all times because it lacks approval [11]. That matters if your sport tests for drugs. It is one part of the BPC-157 legal status, not proof that the compound helps or harms people.